E Fund Management Co., Ltd.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
398
Total Value
2093195771
Accession Number
0001842296-25-000002
Form Type
13F-HR
Manager Name
E Fund Management Co., Ltd.
Data Enrichment
97% identified
385 identified13 unidentified

Holdings

398 positions
Manager:
Search and click to pin securities to the top
Page 19 of 20
Shares:1.4K
Value:$200.5K
Protagonist Therapeutics, Inc
Shares:4.1K
Value:$200.1K
DYNAVAX TECHNOLOGIES CORP
Shares:15.4K
Value:$199.2K
Syndax Pharmaceuticals Inc
Shares:16.0K
Value:$196.9K
AMICUS THERAPEUTICS, INC.
Shares:23.7K
Value:$193.5K
IDEAYA Biosciences, Inc.
Shares:11.3K
Value:$185.8K
Celldex Therapeutics, Inc.
Shares:10.1K
Value:$183.8K
ARDELYX, INC.
Shares:36.8K
Value:$180.5K
68248T204
Shares:26.8K
Value:$179.4K
BIOCRYST PHARMACEUTICALS INC
Shares:23.7K
Value:$177.6K
NOVAVAX INC
Shares:26.0K
Value:$166.4K
Denali Therapeutics Inc.
Shares:12.1K
Value:$164.1K
Dyne Therapeutics, Inc.
Shares:13.8K
Value:$144.0K
IOVANCE BIOTHERAPEUTICS, INC.
Shares:39.4K
Value:$131.2K
GERON CORP
Shares:82.4K
Value:$131.0K
MANNKIND CORP
Shares:24.7K
Value:$124.1K
Nurix Therapeutics, Inc.
Shares:10.3K
Value:$122.2K
MYRIAD GENETICS INC
Shares:13.7K
Value:$121.7K
Intellia Therapeutics, Inc.
Shares:16.8K
Value:$119.7K
Vir Biotechnology, Inc.
Shares:16.0K
Value:$103.6K